175 related articles for article (PubMed ID: 9823980)
1. Expression in human prostate of drug- and carcinogen-metabolizing enzymes: association with prostate cancer risk.
Agúndez JA; Martínez C; Olivera M; Gallardo L; Ladero JM; Rosado C; Prados J; Rodriguez-Molina J; Resel L; Benítez J
Br J Cancer; 1998 Nov; 78(10):1361-7. PubMed ID: 9823980
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in NAT2, CYP2D6, CYP2C19 and GSTP1 and their association with prostate cancer.
Wadelius M; Autrup JL; Stubbins MJ; Andersson SO; Johansson JE; Wadelius C; Wolf CR; Autrup H; Rane A
Pharmacogenetics; 1999 Jun; 9(3):333-40. PubMed ID: 10471065
[TBL] [Abstract][Full Text] [Related]
3. Increased risk for hepatocellular carcinoma in NAT2-slow acetylators and CYP2D6-rapid metabolizers.
Agúndez JA; Olivera M; Ladero JM; Rodriguez-Lescure A; Ledesma MC; Diaz-Rubio M; Meyer UA; Benítez J
Pharmacogenetics; 1996 Dec; 6(6):501-12. PubMed ID: 9014199
[TBL] [Abstract][Full Text] [Related]
4. Implication of Xenobiotic Metabolizing Enzyme gene (CYP2E1, CYP2C19, CYP2D6, mEH and NAT2) polymorphisms in breast carcinoma.
Khedhaier A; Hassen E; Bouaouina N; Gabbouj S; Ahmed SB; Chouchane L
BMC Cancer; 2008 Apr; 8():109. PubMed ID: 18423013
[TBL] [Abstract][Full Text] [Related]
5. Lack of association between human longevity and genetic polymorphisms in drug-metabolizing enzymes at the NAT2, GSTM1 and CYP2D6 loci.
Muiras ML; Verasdonck P; Cottet F; Schächter F
Hum Genet; 1998 May; 102(5):526-32. PubMed ID: 9654200
[TBL] [Abstract][Full Text] [Related]
6. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 (CYP450,2D6*A), N-Acetyltransferase-2 (NAT2*7, A) and Multidrug Resistance 1 (MDR1 3435 T) Alleles Collectively Increase Risk of Ulcerative Colitis.
Lotfi F; Bahrehmand F; Vaisi-Raygani A; Khodarahmi R; Tanhapour M; Kiani A; Rahimi Z; Pourmotabbed T
Arch Iran Med; 2018 Nov; 21(11):530-535. PubMed ID: 30551694
[TBL] [Abstract][Full Text] [Related]
8. Significance of the genetic polymorphism of CYP2D6 and NAT2 in patients with inflammatory bowel diseases.
Dudarewicz M; Rychlik-Sych M; Barańska M; Wojtczak A; Trzciński R; Dziki A; Skrętkowicz J
Pharmacol Rep; 2014 Aug; 66(4):686-90. PubMed ID: 24948072
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphism of CYP2D6, GSTM1 and NAT2 and susceptibility to haematological neoplasias.
Lemos MC; Cabrita FJ; Silva HA; Vivan M; Plácido F; Regateiro FJ
Carcinogenesis; 1999 Jul; 20(7):1225-9. PubMed ID: 10383893
[TBL] [Abstract][Full Text] [Related]
10. CYP2D6, NAT2 and CYP2E1 genetic polymorphisms in nonagenarians.
Agúndez JA; Rodríguez I; Olivera M; Ladero JM; García MA; Ribera JM; Benítez J
Age Ageing; 1997 Mar; 26(2):147-51. PubMed ID: 9177672
[TBL] [Abstract][Full Text] [Related]
11. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
[TBL] [Abstract][Full Text] [Related]
12. Genetic susceptibility to breast cancer in French-Canadians: role of carcinogen-metabolizing enzymes and gene-environment interactions.
Krajinovic M; Ghadirian P; Richer C; Sinnett H; Gandini S; Perret C; Lacroix A; Labuda D; Sinnett D
Int J Cancer; 2001 Apr; 92(2):220-5. PubMed ID: 11291049
[TBL] [Abstract][Full Text] [Related]
13. Variation in N-acetyltransferase 2 (NAT2), smoking and risk of prostate cancer in the Slovak population.
Vilčková M; Jurečeková J; Dobrota D; Habalová V; Klimčáková L; Waczulíková I; Slezák P; Kliment J; Sivoňová MK
Med Oncol; 2014 Jun; 31(6):987. PubMed ID: 24816842
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between genetic polymorphisms of metabolizing enzymes and prostate cancer].
Gao JP; Huang YD; Yang GZ; Yang YQ
Zhonghua Nan Ke Xue; 2003 Feb; 9(1):32-5. PubMed ID: 12680328
[TBL] [Abstract][Full Text] [Related]
15. Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail".
Streetman DS; Bleakley JF; Kim JS; Nafziger AN; Leeder JS; Gaedigk A; Gotschall R; Kearns GL; Bertino JS
Clin Pharmacol Ther; 2000 Oct; 68(4):375-83. PubMed ID: 11061577
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphism of the N-acetyltransferase 2 gene, and susceptibility to prostate cancer: a pilot study in north Indian population.
Srivastava DS; Mittal RD
BMC Urol; 2005 Aug; 5():12. PubMed ID: 16083506
[TBL] [Abstract][Full Text] [Related]
17. Genetic analysis of the NAT2 and CYP2D6 polymorphisms in white patients with non-insulin-dependent diabetes mellitus.
Agúndez JA; Menaya JG; Tejeda R; Lago F; Chávez M; Benítez J
Pharmacogenetics; 1996 Oct; 6(5):465-72. PubMed ID: 8946479
[TBL] [Abstract][Full Text] [Related]
18. Association of CYP1A1 and CYP2D6 gene polymorphisms with head and neck cancer in Tunisian patients.
Khlifi R; Chakroun A; Hamza-Chaffai A; Rebai A
Mol Biol Rep; 2014; 41(4):2591-600. PubMed ID: 24449363
[TBL] [Abstract][Full Text] [Related]
19. Adverse drug reaction monitoring in Jena. Relevance of polymorphic drug metabolizing enzymes for inducing adverse drug reactions.
Hippius M; Buchardt C; Farker K; Kuhn UD; Reimann IR; Hoffmann A
Exp Toxicol Pathol; 2003 Jun; 54(5-6):417-21. PubMed ID: 12877354
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of catechol-0-methyltransferase (COMT), monoamine oxidase B (MAOB), N-acetyltransferase 2 (NAT2) and cytochrome P450 2D6 (CYP2D6) gene in patients with early onset of Parkinson's disease.
Bialecka M; Klodowska-Duda G; Honczarenko K; Gawrońska-Szklarz B; Opala G; Safranow K; Droździk M
Parkinsonism Relat Disord; 2007 May; 13(4):224-9. PubMed ID: 17270484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
